Shao Kang Wang

Amministratore Delegato presso Infervision Medical Technology Co., Ltd.

36 anni

Consumer Services

Technology Services

Profilo

Shao Kang Wang is currently the Executive Director & General Manager at Infervision Medical Technology Co., Ltd.
and a Member-Supervisory Board at Shanghai Infervision Biotechnology Co. Ltd.
He graduated from The University of Chicago in 2012 with a graduate degree and from Beijing Institute of Technology in 2010 with an undergraduate degree.

Posizioni attive di Shao Kang Wang

Società	Posizione	Inizio
Infervision Medical Technology Co., Ltd. Infervision Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Infervision Medical Technology Co., Ltd. engages in the research and development, and provision of artificial intelligence technology in assisting medical image diagnosis. Its AI medical products intended for disease screening and diagnosis, disease intervention and treatment, patient management and medical research, for full-hospital deployment serving physicians from multiple departments. The firm’s products include InferRead Solution and InferScholar Center. The company was founded on January 5, 2016 and is headquartered in Beijing, China.	Amministratore Delegato	05/01/2016
Shanghai Infervision Biotechnology Co. Ltd.	Direttore/Membro del Consiglio	01/01/2020

Tutte le posizioni attive di Shao Kang Wang

Formazione di Shao Kang Wang

The University of Chicago	Graduate Degree
Beijing Institute of Technology	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Shao Kang Wang

Relazioni

100 +

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Infervision Medical Technology Co., Ltd. Infervision Medical Technology Co., Ltd. Packaged SoftwareTechnology Services Infervision Medical Technology Co., Ltd. engages in the research and development, and provision of artificial intelligence technology in assisting medical image diagnosis. Its AI medical products intended for disease screening and diagnosis, disease intervention and treatment, patient management and medical research, for full-hospital deployment serving physicians from multiple departments. The firm’s products include InferRead Solution and InferScholar Center. The company was founded on January 5, 2016 and is headquartered in Beijing, China.	Technology Services
Shanghai Infervision Biotechnology Co. Ltd.